Inventor · disambiguated record
Andrew K. Shiau
Also filed as: SHIAU ANDREW · SHIAU ANDREW K · SHIAU ANDREW KWAN-NAN
18 granted patents·13 pending applications·89 citations·filing 1996–2024
92Inventor score
Files withKALYPSYS INC11AMGEN INC4GOVEK STEVEN P4LUDWIG INST FOR CANCER RES LTD3POSEIDON INNOVATION 1 INC3
Top patents by PatentIndex Score
31 records- 0186US7745646B2Bicyclic heteroaryl inhibitors of PDE4KALYPSYS INC·Filed 2007·Granted Jun 29, 2010·7 cites·22 claims
- 0282US7494999B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2005·Granted Feb 24, 2009·6 cites·9 claims
- 0381US8138205B2Heteroarylalkoxy-substituted quinolone inhibitors of PDE4GOVEK STEVEN P·Filed 2009·Granted Mar 20, 2012·4 cites·19 claims
- 0477US6266622B1Nuclear receptor ligands and ligand binding domainsUNIV CALIFORNIA·Filed 1997·Granted Jul 24, 2001·28 cites·28 claims
- 0577US2025179059A1Anticancer compoundsUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0674US8080563B2Bicyclic heteroaryl inhibitors of PDE4GOVEK STEVEN P·Filed 2007·Granted Dec 20, 2011·1 cites·7 claims
- 0772US7071358B2Arylsulfonamidobenzylic compoundsAMGEN INC·Filed 2003·Granted Jul 4, 2006·6 cites·25 claims
- 0871US12162870B2Anticancer compoundsUNIV CALIFORNIA·Filed 2022·Granted Dec 10, 2024·0 cites·34 claims
- 0971US7834004B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2008·Granted Nov 16, 2010·1 cites·37 claims
- 1070US6236946B1Nuclear receptor ligands and ligand binding domainsFiled 1996·Granted May 22, 2001·32 cites·22 claims
- 1168US8258154B2Bicyclic heteroaryl inhibitors of PDE4GOVEK STEVEN·Filed 2007·Granted Sep 4, 2012·1 cites·13 claims
- 1267US7112606B2Heterocyclic arylsulfonamidobenzylic compoundsAMGEN INC·Filed 2003·Granted Sep 26, 2006·3 cites·8 claims
- 1367US2024208939A1Treatment of autoimmune and inflammatory disorders with inhibitors of bet family bdii bromodomainPOSEIDON INNOVATION 1 INC·Filed 2023·Application pending·0 cites
- 1467US2024226096A1Treatment of myeloproliferative diseases and disorders with inhibitors of bet family bdii bromodomainPOSEIDON INNOVATION 1 INC·Filed 2023·Application pending·0 cites
- 1565US2024217952A1Treatment of graft-versus-host disease with inhibitors of bet family bdii bromodomainPOSEIDON INNOVATION 1 INC·Filed 2023·Application pending·0 cites
- 1662US2009227599A1Sulfonyl-substituted bicyclic compounds as modulators of pparKALYPSYS INC·Filed 2009·Application pending·0 cites
- 1759US7915253B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2008·Granted Mar 29, 2011·0 cites·40 claims
- 1858US9078887B2Bicyclic heteroaryl inhibitors of PDE4GOVEK STEVEN P·Filed 2012·Granted Jul 14, 2015·0 cites·17 claims
- 1957US2010105729A1Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agentsKALYPSYS INC·Filed 2007·Application pending·0 cites
- 2057US2009275586A1Heterocyclic inhibitors of pde4KALYPSYS INC·Filed 2007·Application pending·0 cites
- 2153US11612604B2Methods of treating cancer with PLK4 inhibitorsLUDWIG INST FOR CANCER RES LTD·Filed 2018·Granted Mar 28, 2023·0 cites·20 claims
- 2253US7473703B2Heterocyclic arylsulfonamidobenzylic compoundsAMGEN INC·Filed 2006·Granted Jan 6, 2009·0 cites·9 claims
- 2353US2007190079A1Methods for the selective modulation of pparKALYPSYS INC·Filed 2007·Application pending·0 cites
- 2451US7326812B2Arylsulfonamidobenzylic compoundsAMGEN INC·Filed 2006·Granted Feb 5, 2008·0 cites·9 claims
- 2547US2013045975A1Bicyclic heteroaryl inhibitors of pde4KALYPSYS INC·Filed 2012·Application pending·0 cites
- 2646US2007270434A1Sulfonyl-substituted bicyclic compounds as modulators of pparKALYPSYS INC·Filed 2007·Application pending·0 cites
- 2741US2002152479A1Car modulators: screening and treatment of hypercholesterolemiaFiled 2001·Application pending·0 cites
- 2841US2005234046A1Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disordersKALYPSYS INC·Filed 2005·Application pending·0 cites
- 2940US11253521B23-hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulatorsLUDWIG INST FOR CANCER RES LTD·Filed 2016·Granted Feb 22, 2022·0 cites·20 claims
- 3039US2013116279A1Bicyclic heteroaryl inhibitors of pde4GOVEK STEVEN P·Filed 2011·Application pending·0 cites
- 3138US10752612B2PLK4 inhibitorsLUDWIG INST FOR CANCER RES LTD·Filed 2016·Granted Aug 25, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Andrew K. Shiau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →